In particular, the rare, but recurrent HOXB13 G84E mutation is strongly associated with an increased risk of familial prostate cancer in European descents and subsequently found to be highly associated with prostate cancer risk in additional populations [23,24,25,26,27,28,29,30]. Here, HOXB13 is linked to prostate carcinoma.